3 Things About BioNTech That Smart Investors Know
For most investors, the story of BioNTech (NASDAQ: BNTX) will always start with the pandemic and its partnership with Pfizer (NYSE: PFE) to deliver Comirnaty, the messenger RNA (mRNA) vaccine for COVID-19. It's only natural. But the company's roots are much deeper, based in research for curing another disease, cancer.
The coronavirus vaccine and its history of cancer research are a combination that could produce blockbusters, making its shares worth much more than the market is pricing in. Here's more on these three things smart investors already know about BioNTech.
Image source: Getty Images.
Source Fool.com
